Sartorius strong outperformer in European biotech sector

Because of the huge loss of 43 percent since early this year, the share is one of the worst shares of the biotech sector. The average stock of the biotech sector yielded the this year a profit of 7 percent. Other bad performing shares in the peer group are Akers Biosciences, Galena Biopharma and Alliqua BioMedical. Pharming , Assembly Biosciences and Catalyst Pharmaceutical Partners are among the losers in the sector.

Momentum biotech sector

On average the sector trades costs now 4 times the earnings per share. Currently the sector trades at 2,28 times the book value per share. Since 2012 the sector has a profit of 237 percent and since 2007 a profit of 423 percent.

Over the current book year the total revenue will be 1,55 billion euros (consensus estimates). This is hugely more than 2017's revenue of 1,4 billion euros.

Historical revenues and results Sartorius plus estimates 2018

The analysts expect for 2018 a net profit of 151 million euros. For this year most of the analysts expect a profit per share of 2,33 euros. The PE-ratio therefore is 46,14.

Analysts expect a dividend of 0,53 cents per share. Sartorius's dividend yield thus equals 0,49 percent. The average dividend yield of the biotech companies equals a low 0,5 percent.

Based on the current number of outstanding shares Sartorius's market capitalization 3,68 billion euros. The Sartorius stock was the past 12 months quite unstable. Since last October the stock is even 42 percent higher. This year the stock price moved between 73 and 141 euro. Since 2008 the stock price is almost 3636 percent higher.

Historical stock prices Sartorius

On Friday the stock closed at 107,5 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.